Logo image of IO

ION GEOPHYSICAL CORP (IO) Stock Fundamental Analysis

NYSE:IO - New York Stock Exchange, Inc. - US4620442073 - Common Stock

0.345  -0.02 (-6.68%)

After market: 0.345 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to IO. IO was compared to 63 industry peers in the Energy Equipment & Services industry. IO has a bad profitability rating. Also its financial health evaluation is rather negative. IO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IO had negative earnings in the past year.
IO Yearly Net Income VS EBIT VS OCF VS FCFIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 20M -20M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -23.23%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IO Yearly ROA, ROE, ROICIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 -200 -400 -600 -800 -1K

1.3 Margins

Industry RankSector Rank
OM -14.33%
PM (TTM) -42.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IO Yearly Profit, Operating, Gross MarginsIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, IO has more shares outstanding
The debt/assets ratio for IO is higher compared to a year ago.
IO Yearly Shares OutstandingIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 5M 10M
IO Yearly Total Debt VS Total AssetsIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -7.69, we must say that IO is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of -1.62 indicates that IO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -1.62
Debt/FCF N/A
Altman-Z -7.69
ROIC/WACCN/A
WACCN/A
IO Yearly LT Debt VS Equity VS FCFIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 50M -50M 100M 150M

2.3 Liquidity

IO has a Current Ratio of 0.64. This is a bad value and indicates that IO is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.55 indicates that IO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.55
IO Yearly Current Assets VS Current LiabilitesIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.36% over the past year.
IO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.62%.
The Revenue for IO have been decreasing by -11.14% on average. This is quite bad
EPS 1Y (TTM)20.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.31%
Revenue 1Y (TTM)-23.62%
Revenue growth 3Y-14.69%
Revenue growth 5Y-11.14%
Sales Q2Q%174.01%

3.2 Future

IO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.20% yearly.
Based on estimates for the next years, IO will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y67.43%
EPS Next 2Y37.62%
EPS Next 3Y24.71%
EPS Next 5Y13.2%
Revenue Next Year-10.24%
Revenue Next 2Y7.2%
Revenue Next 3Y1.77%
Revenue Next 5Y4.32%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IO Yearly Revenue VS EstimatesIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
IO Yearly EPS VS EstimatesIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IO Price Earnings VS Forward Price EarningsIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.1
IO Per share dataIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

IO's earnings are expected to grow with 24.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.62%
EPS Next 3Y24.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ION GEOPHYSICAL CORP

NYSE:IO (5/18/2022, 8:04:00 PM)

After market: 0.345 0 (0%)

0.345

-0.02 (-6.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)N/A N/A
Earnings (Next)06-03 2022-06-03/amc
Inst Owners0.16%
Inst Owner Change-0.15%
Ins Owners7.32%
Ins Owner Change0%
Market Cap9.88M
Analysts40
Price Target1.53 (343.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.1
EPS(TTM)-1.76
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.68
BVpS-2.32
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.33%
PM (TTM) -42.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity -1.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.55
Altman-Z -7.69
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.31%
EPS Next Y67.43%
EPS Next 2Y37.62%
EPS Next 3Y24.71%
EPS Next 5Y13.2%
Revenue 1Y (TTM)-23.62%
Revenue growth 3Y-14.69%
Revenue growth 5Y-11.14%
Sales Q2Q%174.01%
Revenue Next Year-10.24%
Revenue Next 2Y7.2%
Revenue Next 3Y1.77%
Revenue Next 5Y4.32%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A